» Articles » PMID: 11483721

Group II Muscle Afferents Probably Contribute to the Medium Latency Soleus Stretch Reflex During Walking in Humans

Overview
Journal J Physiol
Specialty Physiology
Date 2001 Aug 3
PMID 11483721
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

1. The objective of this study was to determine which afferents contribute to the medium latency response of the soleus stretch reflex resulting from an unexpected perturbation during human walking. 2. Fourteen healthy subjects walked on a treadmill at approximately 3.5 km h(-1) with the left ankle attached to a portable stretching device. The soleus stretch reflex was elicited by applying small amplitude (approximately 8 deg) dorsiflexion perturbations 200 ms after heel contact. 3. Short and medium latency responses were observed with latencies of 55 +/- 5 and 78 +/- 6 ms, respectively. The short latency response was velocity sensitive (P < 0.001), while the medium latency response was not (P = 0.725). 4. Nerve cooling increased the delay of the medium latency component to a greater extent than that of the short latency component (P < 0.005). 5. Ischaemia strongly decreased the short latency component (P = 0.004), whereas the medium latency component was unchanged (P = 0.437). 6. Two hours after the ingestion of tizanidine, an alpha(2)-adrenergic receptor agonist known to selectively depress the transmission in the group II afferent pathway, the medium latency reflex was strongly depressed (P = 0.007), whereas the short latency component was unchanged (P = 0.653). 7. An ankle block with lidocaine hydrochloride was performed to suppress the cutaneous afferents of the foot and ankle. Neither the short (P = 0.453) nor medium (P = 0.310) latency reflexes were changed. 8. Our results support the hypothesis that, during walking the medium latency component of the stretch reflex resulting from an unexpected perturbation is contributed to by group II muscle afferents.

Citing Articles

Corticospinal excitability across lower limb muscles in humans.

Eisner-Janowicz I, Chen B, Sangari S, Perez M J Neurophysiol. 2023; 130(3):788-797.

PMID: 37435645 PMC: 10648929. DOI: 10.1152/jn.00207.2023.


Modulation of H-reflex and V-wave responses during dynamic balance perturbations.

Nevanpera S, Hu N, Walker S, Avela J, Piirainen J Exp Brain Res. 2023; 241(6):1599-1610.

PMID: 37142781 PMC: 10224810. DOI: 10.1007/s00221-023-06625-6.


Delayed Onset Muscle Soreness and Critical Neural Microdamage-Derived Neuroinflammation.

Sonkodi B Biomolecules. 2022; 12(9).

PMID: 36139045 PMC: 9496513. DOI: 10.3390/biom12091207.


Clinical neurophysiology of Parkinson's disease and parkinsonism.

Chen R, Berardelli A, Bhattacharya A, Bologna M, Stanley Chen K, Fasano A Clin Neurophysiol Pract. 2022; 7:201-227.

PMID: 35899019 PMC: 9309229. DOI: 10.1016/j.cnp.2022.06.002.


Significantly Delayed Medium-Latency Response of the Stretch Reflex in Delayed-Onset Muscle Soreness of the Quadriceps Femoris Muscles Is Indicative of Sensory Neuronal Microdamage.

Sonkodi B, Hegedus A, Kopper B, Berkes I J Funct Morphol Kinesiol. 2022; 7(2).

PMID: 35736014 PMC: 9224667. DOI: 10.3390/jfmk7020043.


References
1.
Dietz V, Quintern J, Berger W . Cerebral evoked potentials associated with the compensatory reactions following stance and gait perturbation. Neurosci Lett. 1984; 50(1-3):181-6. DOI: 10.1016/0304-3940(84)90483-x. View

2.
Nichols T, Houk J . Improvement in linearity and regulation of stiffness that results from actions of stretch reflex. J Neurophysiol. 1976; 39(1):119-42. DOI: 10.1152/jn.1976.39.1.119. View

3.
Sinkjaer T, Andersen J, LARSEN B . Soleus stretch reflex modulation during gait in humans. J Neurophysiol. 1996; 76(2):1112-20. DOI: 10.1152/jn.1996.76.2.1112. View

4.
Davies J, Johnston S, Hill D, Quinlan J . Tizanidine (DS103-282), a centrally acting muscle relaxant, selectively depresses excitation of feline dorsal horn neurones to noxious peripheral stimuli by an action at alpha 2-adrenoceptors. Neurosci Lett. 1984; 48(2):197-202. DOI: 10.1016/0304-3940(84)90019-3. View

5.
Eriksson J, Olausson B, Jankowska E . Antispastic effects of L-dopa. Exp Brain Res. 1996; 111(2):296-304. DOI: 10.1007/BF00227307. View